Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents

AIDS. 2007 Nov 30;21(18):2387-97. doi: 10.1097/QAD.0b013e3282f13823.

Abstract

Background: Differential protein targeting by HIV-specific CD8 T cells is associated with disparate plasma viral loads; however, it is unclear if the quality of these responses differs depending upon the specificity of the targeted epitopes.

Methods: We examined HIV-specific CD8 T-cell responses in HIV-infected adolescents carrying either an HLA class I allele associated with a favorable prognosis (HLA-B*57) or an allele associated with usual disease progression (HLA-B*35 or HLA-B*53) using interferon-gamma ELISpot and ICS assays.

Results: In an interferon-gamma ELISpot assay, p24 was the dominant protein targeted by B*57 carriers while responses to Nef dominated in B*35 or B*53 positive carriers. This differential protein targeting did not change during 4 years of follow-up. In these chronically infected adolescents, there were no significant differences in the quality of the immunodominant T-cell responses between the B*57 and B*35/B*53 carriers as measured by peptide avidity, degranulation, and immune memory markers. There was a trend towards higher expression of interleukin-2 from B*57-KF11 restricted CD8 T cells although this difference was not significant. Nevertheless both B*57 and B*35/53-restricted responses were relatively potent as reflected by the propensity of CD8 T cells to escape in p24 and Nef, respectively.

Conclusions: Differential protein targeting rather than the quality of T-cell responses appears to be a major distinguishing feature of HIV-specific CD8 T cells induced in B*57 carriers. These data suggest that viral fitness costs associated with CD8 T-cell pressure is an important factor determining differences in the viral load among HIV-infected patients.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Amino Acid Sequence
  • CD8-Positive T-Lymphocytes / immunology
  • Chronic Disease
  • Cross-Sectional Studies
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Gene Products, gag / genetics
  • Gene Products, gag / immunology
  • Genetic Predisposition to Disease
  • HIV Core Protein p24 / genetics
  • HIV Core Protein p24 / immunology
  • HIV Infections / genetics
  • HIV Infections / immunology*
  • HIV Infections / virology
  • HIV-1* / genetics
  • HIV-1* / immunology
  • HLA Antigens / immunology*
  • HLA-B Antigens / immunology
  • HLA-B35 Antigen / immunology*
  • Humans
  • Immunodominant Epitopes / genetics
  • Immunodominant Epitopes / immunology
  • Interleukin-2 / biosynthesis
  • Molecular Sequence Data
  • Mutation
  • Prognosis
  • Viral Load
  • nef Gene Products, Human Immunodeficiency Virus / genetics
  • nef Gene Products, Human Immunodeficiency Virus / immunology

Substances

  • Gene Products, gag
  • HIV Core Protein p24
  • HLA Antigens
  • HLA-B Antigens
  • HLA-B35 Antigen
  • HLA-B53 antigen
  • HLA-B57 antigen
  • Immunodominant Epitopes
  • Interleukin-2
  • nef Gene Products, Human Immunodeficiency Virus
  • nef protein, Human immunodeficiency virus 1
  • p24 protein, Human Immunodeficiency Virus Type 1